{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:19:21Z","timestamp":1787865561129,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013003","name":"University of Cagliari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajoc.2026.102637","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:25:33Z","timestamp":1785338733000},"page":"102637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combined use of insulin eye drops and cross-linked hyaluronic acid canalicular gel for the management of severe neurotrophic keratopathy"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0956-4925","authenticated-orcid":false,"given":"Filippo","family":"Lixi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Corda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Verdiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2410-6366","authenticated-orcid":false,"given":"Giulia","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-0289","authenticated-orcid":false,"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2026.102637_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajoc.2026.102637_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/EB.S117261","article-title":"Neurotrophic keratitis: current challenges and future prospects","volume":"10","author":"Versura","year":"2018","journal-title":"Eye Brain"},{"key":"10.1016\/j.ajoc.2026.102637_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000354380","article-title":"Neurotrophic keratitis","volume":"231","author":"Semeraro","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajoc.2026.102637_bib4","series-title":"StatPearls [Internet]","article-title":"Persistent epithelial defect","author":"Golhait","year":"2025"},{"issue":"2","key":"10.1016\/j.ajoc.2026.102637_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/17469899.2026.2635764","article-title":"Current and emerging medical treatment options for corneal persistent epithelial defects","volume":"21","author":"Lixi","year":"2026","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102637_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40265-025-02147-3","article-title":"Current and emerging therapeutic strategies for the management of neurotrophic keratitis","volume":"85","author":"Lacorzana","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.ajoc.2026.102637_bib7","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.2147\/OPTH.S561775","article-title":"Comparison of amniotic membrane extract and insulin eye drops for the management of persistent epithelial defects: a multicenter retrospective study","volume":"19","author":"Buzzi","year":"2025","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102637_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/ICO.0000000000003308","article-title":"Randomized clinical trial of topical insulin versus artificial tears for healing rates of iatrogenic corneal epithelial defects induced during vitreoretinal surgery in diabetics","volume":"42","author":"Dasrilsyah","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102637_bib9","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1177\/1120672120958307","article-title":"Topical insulin for refractory persistent corneal epithelial defects","volume":"31","author":"Diaz-Valle","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102637_bib10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1167\/iovs.03-1064","article-title":"Insulin, not leptin, promotes in vitro cell migration to heal monolayer wounds in human corneal epithelium","volume":"45","author":"Shanley","year":"2004","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2026.102637_bib11","series-title":"Lacrifill (crosslinked hyaluronate gel) [[prescribing information]] [Internet]","year":"2024"},{"key":"10.1016\/j.ajoc.2026.102637_bib12","unstructured":"Nordin BA. A retrospective crossover study on cross-linked hyaluronic acid gel (Lacrifill) versus cyclosporine a 0.05% (restasis) for dry eye disease. Cureus. 17:e91343. doi:10.7759\/cureus.91343 PubMed PMID: 40895656; PubMed Central PMCID: PMC12399288."},{"key":"10.1016\/j.ajoc.2026.102637_bib13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/j.jcrs.0000000000001505","article-title":"Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye","volume":"50","author":"Packer","year":"2024","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajoc.2026.102637_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ICO.0000000000003361","article-title":"Combined use of therapeutic hyper-cl soft contact lens and insulin eye drops for the treatment of recalcitrant neurotrophic keratopathy","volume":"43","author":"Giannaccare","year":"2024","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ajoc.2026.102637_bib15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.ajpath.2020.08.006","article-title":"Insulin promotes corneal nerve repair and wound healing in type 1 diabetic mice by enhancing Wnt\/\u03b2-Catenin signaling","volume":"190","author":"Yang","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajoc.2026.102637_bib16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/ICO.0000000000002858","article-title":"Topical insulin-utility and results in refractory neurotrophic keratopathy in stages 2 and 3","volume":"41","author":"Soares","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102637_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s40123-026-01446-6","article-title":"Topical insulin for corneal persistent epithelial defects: a multicenter retrospective Study","author":"Lixi","year":"2026","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajoc.2026.102637_bib18","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1111\/aos.14997","article-title":"Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea","volume":"100","author":"Diaz-Valle","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102637_bib19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0000000000003145","article-title":"Healing of chemical injury-related persistent corneal epithelial defects with topical insulin","volume":"42","author":"Balal","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102637_bib20","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1177\/11206721221097584","article-title":"Clinical and instrumental assessment of the corneal healing in moderate and severe neurotrophic keratopathy treated with rh-NGF (Cenegermin)","volume":"32","author":"Roszkowska","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102637_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ajoc.2026.102637_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajo.2022.12.007","article-title":"Comparison of persistent epithelial defect treatment with sutureless cryopreserved and dehydrated amniotic membrane","volume":"251","author":"Sell","year":"2023","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:30:55Z","timestamp":1787862655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993626001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S2451993626001258"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102637","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined use of insulin eye drops and cross-linked hyaluronic acid canalicular gel for the management of severe neurotrophic keratopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102637"}}